Crohns Disease Clinical Trial
Crohn's patients receiving ileocolonic resection are randomized into extensive mesenteric resection group and local mesenteric resection group.
Randomization was performed intraoperatively once the surgeon had determined that there were
no other sites of disease and that either type of anastomosis could be performed safely.
Computer generated randomization was carried out within strata using randomized permuted
blocks to ensure balance of the groups.
All surgery was performed by a single group of surgeons experienced in the surgical treatment
of Crohn's disease. Surgery was performed open or laparoscopically depending on patient
factors and surgeon preference. The resection was performed grossly normal resection margins,
with side-to-side anastomosis. The presence of mesenteric marginal thickening with
confirmation by naked eye assessment of the mucosal aspect of the bowel were used to
establish the limits of the disease.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04989907 -
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
|
||
| Recruiting |
NCT00731172 -
A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease
|
Phase 2 | |
| Active, not recruiting |
NCT00132184 -
Vitamin D Treatment for Crohn´s Disease
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT02476643 -
Integrative Gastroenterology - an Observational Trial
|
||
| Terminated |
NCT01203254 -
Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease
|
Phase 4 | |
| Completed |
NCT00454545 -
Atorvastatin in Moderate Active Crohns Disease
|
Phase 2 | |
| Completed |
NCT01593462 -
Comparative Effectiveness of MR Enterography
|
N/A | |
| Completed |
NCT01769755 -
A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease
|
Phase 1 | |
| Terminated |
NCT01582568 -
EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
|
Phase 4 | |
| Active, not recruiting |
NCT04397263 -
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
|
Phase 3 | |
| Completed |
NCT01947010 -
Pneumococcal Vaccination of Crohn Patients
|
Phase 4 | |
| Terminated |
NCT00946361 -
Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease
|
N/A | |
| Completed |
NCT00940576 -
Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases
|
N/A | |
| Completed |
NCT03981939 -
Perianal Fistula (PAF) Validation and Burden of Illness Study
|
||
| Recruiting |
NCT05452304 -
AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease
|
Phase 1 | |
| Completed |
NCT04885920 -
A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)
|
||
| Recruiting |
NCT02130349 -
IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.
|
N/A | |
| Completed |
NCT01145365 -
Study to Look at Benefit of Surgical Drainage Before Beginning Medical Therapy for Crohns Perianal Fistulas
|
N/A | |
| Completed |
NCT00774982 -
Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients
|
Phase 1 | |
| Active, not recruiting |
NCT04959851 -
A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)
|